Eugenol ameliorates uveitis in mice with experimental autoimmune encephalomyelitis through the suppression of key inflammatory genes

Visual impairment associated with uveitis is among the potential complications in multiple sclerosis (MS) and its animal model, experimental autoimmune encephalomyelitis (EAE). Bioinformatics analyses have shown that some hub genes are closely associated with the molecular mechanisms underlying uvei...

Full description

Saved in:
Bibliographic Details
Main Authors: Sungmoo Hong, Kyungsook Jung, Meejung Ahn, Jeongtae Kim, Changjong Moon, Taekyun Shin
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Animal Cells and Systems
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/19768354.2024.2304557
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850185847714873344
author Sungmoo Hong
Kyungsook Jung
Meejung Ahn
Jeongtae Kim
Changjong Moon
Taekyun Shin
author_facet Sungmoo Hong
Kyungsook Jung
Meejung Ahn
Jeongtae Kim
Changjong Moon
Taekyun Shin
author_sort Sungmoo Hong
collection DOAJ
description Visual impairment associated with uveitis is among the potential complications in multiple sclerosis (MS) and its animal model, experimental autoimmune encephalomyelitis (EAE). Bioinformatics analyses have shown that some hub genes are closely associated with the molecular mechanisms underlying uveitis in EAE. This study evaluated whether 4-allyl-2-methoxyphenol (eugenol) can mitigate the pathogenesis of uveitis in EAE through the interruption of key uveitogenic gene expression. Myelin oligodendrocyte glycoprotein35–55 (MOG) peptide-immunized C57BL/6 mice were injected intraperitoneally with eugenol. The eyeballs and spinal cords of EAE mice with or without eugenol treatment were collected simultaneously and immunohistochemical and molecular biological analyses were conducted. Eugenol treatment significantly ameliorated hindlimb paralysis. Ionized calcium-binding adapter molecule 1 (Iba-1) immunohistochemistry showed that the inflammatory response was significantly reduced in the uvea of eugenol-treated EAE mice compared with vehicle-treated controls. Eugenol also significantly reduced the expression of key uveitogenic genes including C1qb and Tyrobp. The suppressive effect of eugenol on inflammation was also observed in the spinal cord, as determined by the suppression of Iba-1-positive microglial cells. Together, these results suggest that the ameliorative effect of eugenol against EAE uveitis is associated with the suppression of key proinflammatory genes, which may represent targets for the treatment of uveitis.
format Article
id doaj-art-834f0768d7af46efa57c232f77e71c4c
institution OA Journals
issn 1976-8354
2151-2485
language English
publishDate 2024-12-01
publisher Taylor & Francis Group
record_format Article
series Animal Cells and Systems
spelling doaj-art-834f0768d7af46efa57c232f77e71c4c2025-08-20T02:16:33ZengTaylor & Francis GroupAnimal Cells and Systems1976-83542151-24852024-12-01281374410.1080/19768354.2024.2304557Eugenol ameliorates uveitis in mice with experimental autoimmune encephalomyelitis through the suppression of key inflammatory genesSungmoo Hong0Kyungsook Jung1Meejung Ahn2Jeongtae Kim3Changjong Moon4Taekyun Shin5College of Veterinary Medicine and Veterinary Medical Research Institute, Jeju National University, Jeju, Republic of KoreaFunctional Biomaterials Research Center, Korea Research Institute of Bioscience and Biotechnology, Jeongeup-si, Republic of KoreaDepartment of Animal Science, College of Life Science, Sangji University, Wonju, Republic of KoreaDepartment of Anatomy, Kosin University College of Medicine, Busan, Republic of KoreaDepartment of Veterinary Anatomy and Animal Behavior, College of Veterinary Medicine and BK21 Plus Project Team, Chonnam National University, Gwangju, Republic of KoreaCollege of Veterinary Medicine and Veterinary Medical Research Institute, Jeju National University, Jeju, Republic of KoreaVisual impairment associated with uveitis is among the potential complications in multiple sclerosis (MS) and its animal model, experimental autoimmune encephalomyelitis (EAE). Bioinformatics analyses have shown that some hub genes are closely associated with the molecular mechanisms underlying uveitis in EAE. This study evaluated whether 4-allyl-2-methoxyphenol (eugenol) can mitigate the pathogenesis of uveitis in EAE through the interruption of key uveitogenic gene expression. Myelin oligodendrocyte glycoprotein35–55 (MOG) peptide-immunized C57BL/6 mice were injected intraperitoneally with eugenol. The eyeballs and spinal cords of EAE mice with or without eugenol treatment were collected simultaneously and immunohistochemical and molecular biological analyses were conducted. Eugenol treatment significantly ameliorated hindlimb paralysis. Ionized calcium-binding adapter molecule 1 (Iba-1) immunohistochemistry showed that the inflammatory response was significantly reduced in the uvea of eugenol-treated EAE mice compared with vehicle-treated controls. Eugenol also significantly reduced the expression of key uveitogenic genes including C1qb and Tyrobp. The suppressive effect of eugenol on inflammation was also observed in the spinal cord, as determined by the suppression of Iba-1-positive microglial cells. Together, these results suggest that the ameliorative effect of eugenol against EAE uveitis is associated with the suppression of key proinflammatory genes, which may represent targets for the treatment of uveitis.https://www.tandfonline.com/doi/10.1080/19768354.2024.2304557Anti-inflammationeugenolexperimental autoimmune encephalomyelitisneuroinflammationuveitis
spellingShingle Sungmoo Hong
Kyungsook Jung
Meejung Ahn
Jeongtae Kim
Changjong Moon
Taekyun Shin
Eugenol ameliorates uveitis in mice with experimental autoimmune encephalomyelitis through the suppression of key inflammatory genes
Animal Cells and Systems
Anti-inflammation
eugenol
experimental autoimmune encephalomyelitis
neuroinflammation
uveitis
title Eugenol ameliorates uveitis in mice with experimental autoimmune encephalomyelitis through the suppression of key inflammatory genes
title_full Eugenol ameliorates uveitis in mice with experimental autoimmune encephalomyelitis through the suppression of key inflammatory genes
title_fullStr Eugenol ameliorates uveitis in mice with experimental autoimmune encephalomyelitis through the suppression of key inflammatory genes
title_full_unstemmed Eugenol ameliorates uveitis in mice with experimental autoimmune encephalomyelitis through the suppression of key inflammatory genes
title_short Eugenol ameliorates uveitis in mice with experimental autoimmune encephalomyelitis through the suppression of key inflammatory genes
title_sort eugenol ameliorates uveitis in mice with experimental autoimmune encephalomyelitis through the suppression of key inflammatory genes
topic Anti-inflammation
eugenol
experimental autoimmune encephalomyelitis
neuroinflammation
uveitis
url https://www.tandfonline.com/doi/10.1080/19768354.2024.2304557
work_keys_str_mv AT sungmoohong eugenolamelioratesuveitisinmicewithexperimentalautoimmuneencephalomyelitisthroughthesuppressionofkeyinflammatorygenes
AT kyungsookjung eugenolamelioratesuveitisinmicewithexperimentalautoimmuneencephalomyelitisthroughthesuppressionofkeyinflammatorygenes
AT meejungahn eugenolamelioratesuveitisinmicewithexperimentalautoimmuneencephalomyelitisthroughthesuppressionofkeyinflammatorygenes
AT jeongtaekim eugenolamelioratesuveitisinmicewithexperimentalautoimmuneencephalomyelitisthroughthesuppressionofkeyinflammatorygenes
AT changjongmoon eugenolamelioratesuveitisinmicewithexperimentalautoimmuneencephalomyelitisthroughthesuppressionofkeyinflammatorygenes
AT taekyunshin eugenolamelioratesuveitisinmicewithexperimentalautoimmuneencephalomyelitisthroughthesuppressionofkeyinflammatorygenes